| Logo | Name | Σ |
|---|---|---|
 | Eurofins Scientifique With ca. 63,000 staff across 60 countries, Eurofins provides testing, inspection, and certification services. Since 1987, Eurofins has grown from one laboratory in Nantes, France to ca. 63,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO … Tags: CAC40 Sectors: | 286 |
 | Cryoport Systems (formerly Cell&Co) A Cryoport Company - ATMP & Clinical sample management - www.cell-and-co.com Expert in GMP products management & Clinical sample management activities, Cell&Co BioServices, subsidiary of Cryoport Systems, offers a complete one-stop-shop solution for managing GMP-products and biological-samples. Our mission is to give you a reliable solution of storage, packaging, traceability, and trustfull logistic services. Cell&Co is the first and most important french private biorepository ; recognized, certified and having regulatory authorizations, with the highest and non challenged capacity. With two GMP plants, Cell&Co is offering mirroring storage capacities from -196°C to +20°C. We mainly support our clients by providing the … Sectors: | 18 |
 | CEBINA Central European Biotech Incubator and Accelerator At CEBINA (Central European Biotech Incubator and Accelerator), we go beyond a traditional biotechnology incubator - uniquely supporting life science entrepreneurs and young biotech companies through all stages of early company development, transforming promising new ideas into fully formed biotech companies that are attractive for investment. Sectors: | 15 |
 | Campus Biotech Campus Biotech is a Swiss center of excellence in biotechnology and life sciences research. Campus Biotech is a new centre of excellence in biotechnology and life science research. It focuses on pure science and its translation into practical outcomes that have an impact on society and the world. Campus Biotech is expected to generate a vast range of opportunities, bringing impetus and investment to this vital economic and scientific sector. Sectors: | 116 |
 | Biogen Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth. With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we … Sectors: | 714 |
 | bioMérieux Pioneering Diagnostics A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety. in vitro … Sectors: | 456 |
 | INVIVOLIM The network of actors in life sciences and biotechnology in Limousin Invivolim is the network of business and biotechnology science companies in Limousin. This network brings together companies, researchers and communities involved in the field of life sciences and biotechnologies in the Limousin territory. Invivolim intervenes to support companies in the territory in their desire to innovate, mobilize and promote the skills of researchers and industrialists to offer original, innovative solutions, and promote the economic development of businesses and the attractiveness of the Limousin and New Aquitaine territory. Biotechnologies represent a fairly broad field of activity: our companies take care … Sectors: | 42 |
 | Lyonbiopôle Auvergne-Rhône-Alpes The health innovation network As a French leading biocluster, Lyonbiopole Auvergne-Rhône-Alpes aims to federate the actors of innovation, to connect and promote them internationally and to support the emergence and development of innovative technologies, products and services to address global healthcare challenges. Lyonbiopole Auvergne-Rhône-Alpes gathers a community of more than 250 members among which world-class leaders, innovative small and medium size companies, research centers and university hospitals. At the center of this ecosystem, Lyonbiopole brings its members altogether to imagine the future of medicine and to develop breakthrough healthTech innovation available for tomorrow’s patients. Sectors: | 470 |
 | Bioeconomy For Change With a membership of more than 500 leading biobased enterprises, B4C is your gateway to the Bioeconomy Bioeconomy For Change est le réseau de la Bioéconomie. Fort de 500 adhérents, nous rassemblons les acteurs actifs et innovants sur l’ensemble de la chaine de valeur de la bioéconomie, depuis l’amont agricole jusqu’à la mise sur le marché de produits finis : coopératives agricoles, établissements de recherche et universités, entreprises de toutes tailles, acteurs publics... Bioeconomy For Change et ses adhérents couvrent tous les champs de la production et de la valorisation des ressources biologiques (terre, bois, mer et déchets) pour des … Sectors: | 372 |
 | Eurobiomed The service catalyst for the community of healthcare innovators in the south of France. Created in 2005, the Eurobiomed competitiveness cluster helps to unite and position the healthcare ecosystem of the Provence-Alpes-Côte-d'Azur and Occitanie/Pyrénées-Méditerranée regions at the cutting edge of innovation. Its aim is to foster the growth and projects of innovative healthcare companies in the region. From immunology and dermatology to neurology, oncology and digital health, Eurobiomed supports French and European public economic development strategies, helping to position its members as European champions and anchor France among the world leaders in healthcare innovation. Eurobiomed brings together all healthcare players, … Sectors: | 434 |
 | BioValley France Pôle de compétitivité santé du Grand Est Pôle de compétitivité Santé du Grand Est, BioValley France (ex Alsace BioValley) a pour mission de fédérer, développer et faire rayonner les acteurs de la filière à travers l’Innovation. Le Pôle s’appuie sur un réseau dynamique d’entreprises, une recherche académique et clinique de premier plan, ainsi qu’un réseau intégré de partenaires, acteurs-clés de l’innovation. BioValley France accompagne ses membres dans leur démarche d’Innovation R&D et leur permet d’accéder à des expertises à forte valeur ajoutée, dans une approche marché. BioValley France participe activement aux projets structurants et collaboratifs du territoire. Il contribue notamment … Sectors: | 429 |
 | Atlanpole Biotherapies Thinking up tomorrow's medicine Atlanpole Biotherapies is a French biocluster that gives you access to extended skills, from biodiagnostic to biomedicine. For pharmaceutical and biotech companies or research laboratories looking for high level partners committed to healthcare and biotechnologies, Atlanpole Biotherapies is a biocluster that draws together a network of industrial and academic competences which offers comprehensive and competitive solutions along the entire biotherapeutic value chain, from discovery to patient,within 4 areas of excellence: • immunobiotherapies • radiopharmaceuticals • biomaterials • cell & gene therapies More information : http://www.atlanpolebiotherapies.com Biotechnologies, Bioproduction, Pharma, Technologies médicales innovantes, MedTech, Numérique pour la santé, … Sectors: | 327 |
 | Genopole Genopole, biocluster leader en France, Vivre l'innovation Created in 1998, Genopole® has a threefold mission: - develop a high-level research campus in genomics and post-genomics, focused on gene therapy in collaboration with the University Evry-Paris Saclay, - encourage the start-up and foster the development of biotech companies in the Paris region by providing personalized advice and support, including financial assistance - create a biopark in Evry-Courcouronnes in collaboration with the research campus. biocluster, research campus - academical laboratories, biotech companies, university, life sciences companies, Infrastructure - Shared-use technology platforms, and Biotherapy Sectors: | 328 |
 | France Biotech Entrepreneurs in HealthTech Created in 1997, the association is the French non-profit organization that brings together the country's leading innovative health compagnies and their expert partners (investors, lawyers, research institutes, cluster, etc...). Its core mission is to promote health innovation in France and help the sector's start-up companies and SMEs to become tomorrow's leaders able to rapidly develop new therapeutic solutions. Our Missions: To support innovative start-ups and SMEs of the HealthTech industry (biotech, medtech, digital health, big data) by tackling four major issues: - Financial: encourage investment in health innovation - Tax: ensure fiscal stability - Administrative and regulatory: … Sectors: | 903 |
 | Eurasanté Accélérateur des innovations santé-nutrition, bien vieillir en région Hauts-de-France Eurasanté is a regional economic development agency specialized in the the health sector. It supports the different actors dedicated to health related activities with their research, creation and development projects. The Biology, Nutrition and Health Sector of the Nord-Pas-De-Calais represents 800 companies, and 22 000 employees. Located at the heart of a business park of over 300 hectares gathering 7 hospitals, 50 research laboratories, 145 companies, 4 universities, 5 specialized training institutes, it constitutes a unique business environment in the largest university-hospital campus over Europe. 3 kinds of services are part … Sectors: | 552 |
 | Biopole Clermont-Limagne The Biopôle Clermont-Limagne has 3 locations ready to welcome business and offers 20 000 m2 of rental solutions for bio-industry activities. Thanks to the wealth and the diversity of its housing stock, the Biopôle Clermont-Limagne can popose to bio-entrepreneurs solutions adapted to their needs. Right by the A71 motorway towards Paris, all three locations are only minutes apart and they are also close to the international airport and the main centres of research in the Clermont area. SAINT-BEAUZIRE SITE : business incubator, business accelerator, on-site construction RIOM SITE : facilities designed for preclinical/health development activities CLERMONT-FERRAND SITE : a building … Sectors: | 57 |
 | Roche Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, … Sectors: | 1652 |
 | Gilead Sciences Creating Possible At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines Sectors: | 829 |
 | Regeneron At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An … Sectors: | 378 |
 | NeuroTechX The International NeuroTech Community NeuroTechX brings hackers, enthusiasts and experts together to drive innovation and foster collaboration at local and international scales. Our core mission is to build a strong global neurotech community by providing key resources, learning opportunities, and by being leaders in local and worldwide technological initiatives. We believe neurotechnology is key to better understanding and to improving who we are. Join us to take part in the conversation and help shape the future of neurotechnology! ---- Chapters in Montreal, Toronto, San Francisco, NYC, Boston, Los Angeles, Paris, Amsterdam, Tel Aviv.... Join us! Sign up for the newsletter … Sectors: | 169 |
 | Moderna Our mission is to deliver the greatest possible impact to people through mRNA medicines. At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using … Sectors: | 724 |
 | Illumina Unlocking the Power of the Genome At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of … Sectors: | 224 |
 | Illumina For Startups Illumina for Startups supporting genomics and multi-omics startups across the globe. Illumina for Startups Network aims to inspire the creation, funding, and growth of genomics and multi-omics startups across the globe. It is designed for the entrepreneurial ecosystem and focused on building connections, strengthening community, and advancing breakthrough genomics applications. Current Illumina for Startups initiatives include Startups Grants for founders to work with Illumina sites to run proof-of-concept sequencing experiments. For more information visit https://www.illumina.com/company/illumina-for-startups.html Past initiatives include Illumina Accelerator, company creation engine co-located with Illumina research and development sites in San Francisco Bay Area and Cambridge, UK. Illumina Accelerator … Sectors: | 917 |
 | Amgen #WeareBiotech Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen … Sectors: | 1648 |
 | Alexion Pharmaceuticals, Inc. Transforming Lives, Every Day. Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, supportive technologies, and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion recognizes that patients and caregivers are people first, and by understanding their experiences, Alexion is better able to serve their unique needs. Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex … Sectors: | 272 |
 | Merck Group This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, … Tags: DAX30 Sectors: | 1529 |
 | IDEXX To enhance the health and well-being of pets, people, and livestock 10,000+ people, one global focus - enhancing the health and well-being of pets, people, and livestock We are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of disease, it’s no wonder that what we do each day is more than just a job. There’s an energy across IDEXX that is contagious – where caring and committed … Sectors: | 78 |
 | Vertex Pharmaceuticals Sectors: | 646 |
Biotechnology